Assembly Biosciences, Inc.
ASMB
$30.82
$0.411.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 477.26% | 57.62% | 12.81% | 62.82% | 2.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 477.26% | 57.62% | 12.81% | 62.82% | 2.71% |
| Cost of Revenue | 20.80% | 22.73% | -0.82% | 25.02% | 29.75% |
| Gross Profit | 464.28% | 13.07% | 15.88% | 10.86% | -80.15% |
| SG&A Expenses | 17.60% | 18.64% | 2.61% | -2.72% | -47.07% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.02% | 21.75% | -0.08% | 17.23% | -4.18% |
| Operating Income | 271.69% | 0.67% | 9.10% | 7.34% | 8.12% |
| Income Before Tax | 312.18% | 4.34% | 5.10% | 2.85% | 4.74% |
| Income Tax Expenses | -- | -- | -- | -- | -330.30% |
| Earnings from Continuing Operations | 313.74% | 4.34% | 8.55% | 2.85% | 5.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 313.74% | 4.34% | 8.55% | 2.85% | 5.72% |
| EBIT | 271.69% | 0.67% | 9.10% | 7.34% | 8.12% |
| EBITDA | 272.44% | 0.66% | 9.12% | 7.38% | 7.76% |
| EPS Basic | 182.46% | 52.10% | 32.60% | 29.04% | 23.22% |
| Normalized Basic EPS | 181.86% | 52.10% | 30.05% | 29.04% | 22.42% |
| EPS Diluted | 182.46% | 52.10% | 32.60% | 29.04% | 23.22% |
| Normalized Diluted EPS | 181.86% | 52.10% | 30.05% | 29.04% | 22.42% |
| Average Basic Shares Outstanding | 159.20% | 99.74% | 35.68% | 36.89% | 22.80% |
| Average Diluted Shares Outstanding | 159.20% | 99.74% | 35.68% | 36.89% | 22.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |